MDS Hub

In case you missed it:
What are the key updates to the classification of MDS in the 5th edition of the @WHO Classification of Haematolymphoid Tumours?
Check out our visual abstract summarizing the main changes
👉 loom.ly/8nbWuCY.
#MDSsm

Has the IPSS-M model changed the extent of the molecular testing you perform for patients with MDS?

Want to find out how the IPSS-R and IPSS-M stratification systems for MDS compare? Find out in our editorial theme article outlining the development of these systems and their pros and cons.

👉 loom.ly/l7pFhKk

#MDS #leusm

A big thank you to our funders, who make it possible for us to deliver the MDS Hub

Bristol Myers Squibb
ThermoFisher Scientific
Astex

All content is developed independently by SES in collaboration with an expert steering committee; funders are allowed no direct influence on the content of the hub.

🎬 Discover the latest insights on MDS classification systems! Join Pierre Fenaux as he delves into his updated approach in our new video. Don't miss this pivotal discussion from our MDS Hub Steering Committee meeting.

👉 loom.ly/Setfq8s

#MDS #MedicalScience